Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study

by Carmen Domínguez-Baleón, Jue-Sheng Ong, Clemens R. Scherzer, Miguel E. Rentería, Xianjun Dong
Published 2021

Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients

by Faith L. Anderson, Katharine M. von Herrmann, Angeline S. Andrew, Yuliya I. Kuras, Alison L. Young, Clemens R. Scherzer, William F. Hickey, Stephen L. Lee, Matthew C. Havrda
Published 2021

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

by Young Eun Huh, Hyejung Park, Ming Sum Ruby Chiang, Idil Tuncali, Ganqiang Liu, Joseph J. Locascio, Julia Shirvan, Samantha J. Hutten, Melissa S. Rotunno, Catherine Viel, Lamya S. Shihabuddin, Bing Wang, Sergio Pablo Sardi, Clemens R. Scherzer
Published 2021